GlassScriptPhysician profile
Glenmore Hendricks
NPI 1720293277
$2,052.82
in general payments reported to CMS, 2019-2025
16 companies · $719 in 2025
The $719 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $123 · 2023: $296 · 2024: $808 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $228.74 | 2021-2025 | |
| Amgen INC. | $223.92 | 2024-2025 | Krystexxa |
| Alnylam Pharmaceuticals INC. | $214.11 | 2024-2025 | Amvuttra, Givlaari |
| Teleflex LLC | $169.24 | 2024 | Urolift |
| Regeneron Pharmaceuticals, INC. | $149.98 | 2025 | Dupixent |
| Lilly USA, LLC | $141.33 | 2023-2025 | Mounjaro, Zepbound |
| Averitas Pharma INC. | $128.15 | 2024 | Qutenza |
| Regeneron Healthcare Solutions, INC. | $126.38 | 2025 | Dupixent |
| Dynavax Technologies Corporation | $122.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $122.84 | 2023 | Rexulti |
| Abbvie INC. | $119.88 | 2024 | |
| Genzyme Corporation | $106.28 | 2024 | |
| Janssen Pharmaceuticals, INC | $91.98 | 2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $58.80 | 2024 | Austedo Xr |
| Si-Bone, INC. | $27.96 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $20.28 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenmore Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.